Suppression of serum gonadal steroids in rats by chronic treatment with dopamine and serotonin reuptake inhibitors

European Neuropsychopharmacology

Volumn 10, Issue 3, 2000, Pages 145-150

  Rehavi, Moshe ^a   Attali, Gitit ^a   Gil Ad, Irit ^a   Weizman, Abraham ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Dopamine transporter; Estradiol; Gonadal hormones; Progesterone; Prolactin; Serotonin transporter; Testosterone

Indexed keywords

BENZATROPINE; CLOMIPRAMINE; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; ESTRADIOL; FLUVOXAMINE; MAZINDOL; PROGESTERONE; PROLACTIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE INHIBITION; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RAT; SEXUAL DYSFUNCTION;

EID: 0034001297     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(00)00066-3     Document Type: Article

References (46)

1. Abraham G.E., O'dell W.D., Swerdloff R.S., Hopper K. Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone and estradiol-17β during the menstrual cycle. J. Clin. Endocrinol. Metab. 34:1972;316-321.
2. Annunziato L., Leblanc P., Kordon C., Weiner R.I. Differences in the kinetics of dopamine uptake in synaptosome preparations of the median eminence relative to other dopaminergically innervated brain areas. Neuroendocrinology. 31:1980;316-320.
3. Baischer W., Koining G., Hartmann B., Huber J., Langer G. Hypothalamic-pituitary axis in depressed prememopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology. 20:1995;553-559.
4. Baldwin D.S., Thomas S.C., Birtwistle J. Effects of antidepressant drugs on sexual function. Int. J. Psych. Clin. Pract. 1:1997;47-58.
5. Beach J.E., Miles D.J., Lukes Y.G., Vigersky R.A. Microplate solid-phase radioimmunoassay for rat prolactin. J. Lab. Clin. Med. 105:1985;294-298.
6. Brandt M.E., Puett D., Zimnski J. Divergence between ovarian aromatase activity, estrogen and androgen levels in the cycling rat. Endocrinology. 126:1990;72-79.
7. Briley M.S., Langer S.Z., Raisman R., Sechter D., Zarifian E. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science. 209:1980;303-305.
8. Butcher R.L., Collins W.E., Fugo N.W. Plasma concentration of LH, FSH, prolactin and estradiol 17β throughout the 4-day estrous cycle of the rat. Endocrinology. 94:1974;1704-1708.
9. Cella S., Apud J., Racagni G., Muller E.E. Dopamine reuptake inhibitors and dopamine releasers; differential effect on plasma prolactin in the rat. Pharmacol. Res. Commun. 14:1982;839-848.
10. Cella S., Penelva A., Locatelli V., Novelli A., Cocchi D., Muller E.E. Neuroendocrine studies with fluvoxamine: animal data. Br. I. Clin. Pharmacol. 15:1983;357S-364S.
11. Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev. Neurosci. 5:1994;27-42.
12. Eyal S., Weizman A., Toren P., Dor Y., Mester R., Rehavi M. Chronic GnRH agonist administration down-regulates platelet serotonin transporter in women undergoing assisted reproductive treatment. Psychopharmacology. 125:1996;141-145.
13. Fink G. The psychoprotective action of estrogen is mediated by central serotonergic as well as dopaminergic mechanisms. Takada A., Curzon G. Serotonin in the Central Nervous System and Periphery. 1995;175-187 Elsevier, Amsterdam.
14. Haberland N., Hetey L. Alterations of the synaptosomal catecholamine uptake in postmortem brain regions in schizophrenia. J. Neural. Transm. 68:1987;303-313.
15. Hedger M.P., Khatab S., Gonzales G., de Kretser D.M. Acute and short-term actions of serotonin administration on the pituitary-testicular axis in the adult rat. Reprod. Fertil. Dev. 7:1995;1101-1109.
16. Horn A.M., Fink G. Effects of 5-hydroxytryptamine uptake blockers on the release of LH and prolactin in several different experimental steroid models in the rat. J. Endocrinol. 104:1985;397-406.
17. 3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol Pharmacol. 26:1984;35-44.
18. Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparation of rat brain. J. Pharmacol. Exp. Ther. 199:1976;649-661.
19. Kubasik N.P., Hallaur G.D., Brodows R.G. Evaluation of a direct solid-phase radioimmunoassay for progesterone. Clin. Chem. 30:1984;284-286.
20. Maier U., Koining G. Andrological findings in young patients under long-term antidepressive therapy with clomipramine. Psychopharmacology. 116:1994;357-359.
21. McCann S.M., Krulich L. Role of transmitters in control of anterior pituitary hormone release. De Groot L.J. 2nd Edition Endocrinology. Vol. 1:1989;117-130 W.B. Saunders, Philadelphia, PA.
22. McEwen B.S. Steroids and brain function. Trends Pharmacol. Sci. 6:1985;22-26.
23. McEwen B.S. Ovarian steroids have diverse effects on brain structure and function. Berg G., Hammar M. The Modern Management of the Menopause. 1994;269-278 Parthenon Publishing, Park Ridge, NJ.
24. McEwen B.S., Gould E Orchinik M., Weiland N.G Woolley C.S. Oestrogens and the structural and functional plasticity of neurons: implications for memory, aging and neurodegenerative processes. Non-reproductive Actions of Sex Steroids. Ciba Foundation Symposium 191. 1995;52-73 Wiley, Chichester.
25. Modell G.J., Katholi C.R., Modell J.D., DePalma R.L. Comparative sexual side effects of bupropion, fluoxetine, paroxetine and sertraline. Clin. Pharmacol. Ther. 61:1997;476-487.
26. Morissette M., Di Paolo T. Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites. J. Neurochem. 60:1993;1876-1883.
27. Morissette M., Di Paolo T. Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology. 58:1993;16-22.
28. Muller E.E., Locatelli V., Cella S., Penalva A., Novelli A., Cocchi D. Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications. Drugs. 25:1983;399-432.
29. Negro-Vilar A., Ojeda S.R., McCann S.M. Catecholaminergic modulation of luteinizing hormone-releasing hormone release by median eminence terminals in vitro. Endocrinology. 104:1979;1749-1757.
30. Newman A.H., Kline R.H., Allen A.C., Izenwassez S., George C., Katz J.L. Novel 4′-substituted and 4′,4″-disubstituted 3α-(diphenyl methoxy) tropane analogs as potent and selective dopamine uptake inhibitors. J. Med. Chem. 38:1994;3933-3940.
31. O'Malley B.W., Tsai S.Y., Bagchi M., Weigel N.L., Schrader W.T., Tsai M.J. Molecular mechanisms of action of sex steroid receptor. Rec. Progr. Horm. Res. 47:1991;1-26.
32. 3H]imipramine binding in male rat frontal cortex. Eur. J. Pharmacol. 107:1985;395-396.
33. Rehavi M., Sepcuti H., Weizman A. Upregulation of imipramine binding and serotonin uptake by estradiol in female rat brain. Brain Res. 410:1987;135-139.
34. Richelson E., Nelson A. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J. Pharmacol. Exp. Ther. 230:1984;94-102.
35. Richelson E., Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104:1984;277-286.
36. Ruzas C., Limonta P., Martini L. Role of serotonergic neurons in the control of gonadotropin and prolactin secretion in the rat. J. Endocrinol. 94:1982;83-89.
37. Seeman P., Niznik H.B. Dopamine receptors and transporters in Parkinson disease and schizophrenia. FASEB J. 4:1990;2737-2744.
38. Segraves R.T. Antidepressant-induced sexual dysfunction. J. Clin. Psychiatry. 59:(Suppl. 4):1998;48-54.
39. Sekiya K., Okajima T., Kato K., Ibayashi H. Acute effects of mazindol on the secretion of ACTH, beta-lipotropin, beta-endorphine and cortisol in man. Endocrinol. Jpn. 31:1984;523-528.
40. Singer H.S., Hahn B.A., Moran T.H. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann. Neurol. 30:1991;558-562.
41. Taylor G., Bardgett M., Cernansky J., Early T., Haller J., Scherrer J., Womack S. Male reproductive systems under chronic fluoxetine or trimipramine treatment. Physiol. Behav. 59:1996;479-485.
42. Toren P., Dor J., Mester R., Mozes T., Blumensohn R., Rehavi M., Weizman A. Depression in women treated with a gonadotropin-releasing hormone agonist. Biol. Psychiatry. 39:1996;378-382.
43. Vijayan E., McCann S.M. Re-evaluation of the role of catecholamines in control of gonadotropin and prolactin release. Neuroendocrinology. 25:1978;150-165.
44. Vijayan E., McCann S.M. The effects of systemic administration of dopamine and apomorphine on plasma LH and prolactin concentrations in conscious rats. Neuroendocrinology. 25:1978;221-235.
45. Vitale M.L., Chiocchio S.R. Serotonin, a neurotransmitter involved in the regulation of luteinizing hormone release. Endocrine Rev. 14:1993;480-493.
46. Weizman A., Carmi M., Hermesh H., Shahar A., Apter A., Tyano S., Rehavi M. High affinity imipramine binding and serotonin uptake in platelets of adolescent and adult obsessive compulsive patients. Am. J. Psychiatry. 143:1986;335-339.